PHARMACOLOGY OF BINDING OF H-3 SCH-23390 TO D-1 DOPAMINERGIC RECEPTOR-SITES IN RAT STRIATAL TISSUE

被引:68
作者
FAEDDA, G
KULA, NS
BALDESSARINI, RJ
机构
[1] MCLEAN HOSP,MAILMAN RES CTR,115 MILL ST,BELMONT,MA 02178
[2] HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115
关键词
D O I
10.1016/0006-2952(89)90387-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:473 / 480
页数:8
相关论文
共 44 条
[1]   EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR [J].
ANDERSEN, PH ;
BRAESTRUP, C .
JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) :1822-1831
[2]   A COMPARISON BETWEEN DOPAMINE-STIMULATED ADENYLATE-CYCLASE AND H-3-SCH-23390 BINDING IN RAT STRIATUM [J].
ANDERSEN, PH ;
GRONVALD, FC ;
JANSEN, JA .
LIFE SCIENCES, 1985, 37 (21) :1971-1983
[3]  
BALDESSARINI RJ, 1985, CHEMOTHERAPY PSYCHIA, P14
[4]   RELATIVE ACTIVITIES OF SCH 23390 AND ITS ANALOGS IN 3 TESTS FOR D1/DA1 DOPAMINE RECEPTOR ANTAGONISM [J].
BARNETT, A ;
AHN, H ;
BILLARD, W ;
GOLD, EH ;
KOHLI, JD ;
GLOCK, D ;
GOLDBERG, LI .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 128 (03) :249-253
[5]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[6]   DECREASING SENSITIVITY TO NEUROLEPTIC AGENTS IN DEVELOPING RATS - EVIDENCE FOR A PHARMACODYNAMIC FACTOR [J].
CAMPBELL, A ;
BALDESSARINI, RJ ;
TEICHER, MH .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :46-51
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[9]  
CHRISTENSEN I, 1986, ARZNEIMITTEL-FORSCH, V36-1, P855
[10]  
CHRISTENSSON EG, 1985, ACTA PHYSIOL SCAND, V124, P281